These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 3398448)
61. [Clinical features and up-to-date therapy of hypertensive emergencies]. Meyer FP Dtsch Med Wochenschr; 2004 Apr; 129(14):768; author reply 768-9. PubMed ID: 15042498 [No Abstract] [Full Text] [Related]
62. [Treatment of hypertensive crisis by the sublingual route: a call for prudence]. Medraño Martínez JC; Gómez Cerezo J; Cobo Mora J; Juárez Alonso S Rev Clin Esp; 1989 Mar; 184(4):209. PubMed ID: 2740552 [No Abstract] [Full Text] [Related]
63. Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. Jegasothy R; Paranthaman S J Obstet Gynaecol Res; 1996 Feb; 22(1):21-4. PubMed ID: 8624887 [TBL] [Abstract][Full Text] [Related]
71. [The structural-functional status of the myocardium and central and regional hemodynamics in patients with essential hypertension under the influence of treatment with korinfar and its combination with anaprilin]. Polivoda SN; Fushteĭ IM; Khalil AA Lik Sprava; 1995; (9-12):32-4. PubMed ID: 8983784 [No Abstract] [Full Text] [Related]
72. [Therapy of the hypertensive crisis]. Grabensee B Dtsch Med Wochenschr; 1985 Nov; 110(45):1738-40. PubMed ID: 2865121 [No Abstract] [Full Text] [Related]
73. [Role of calcium antagonists in the treatment of arterial hypertension]. Belousov IuB Kardiologiia; 1991 Apr; 31(4):5-9. PubMed ID: 2067182 [No Abstract] [Full Text] [Related]
74. [Cardiac insufficiency: current aspects of treatment]. Vitola D; Costa R; Rodrigues R Arq Bras Cardiol; 1989 Sep; 53(3):143-6. PubMed ID: 2698132 [No Abstract] [Full Text] [Related]
75. Clinical effect and safety of nifedipine controlled-release tablets combined with valsartan in the treatment of primary hypertension. Liu W; Liu Y; Fu J Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2419-2422. PubMed ID: 31894027 [TBL] [Abstract][Full Text] [Related]
76. [Usefulness of long-acting Ca antagonist in hypertensive patients with metabolic syndrome]. Takishita S Nihon Rinsho; 2006 Dec; 64 Suppl 9():607-10. PubMed ID: 17458290 [No Abstract] [Full Text] [Related]
78. FDA approves i.v. calcium-channel blocker. Thompson CA Am J Health Syst Pharm; 2008 Sep; 65(18):1686. PubMed ID: 18768991 [No Abstract] [Full Text] [Related]
79. Sublingual nifedipine in human pregnancy. Gallery ED; Györy AZ Aust N Z J Med; 1997 Oct; 27(5):538-42. PubMed ID: 9404584 [TBL] [Abstract][Full Text] [Related]
80. Sublingual nifedipine controversy in drug delivery. Schumann D Dimens Crit Care Nurs; 1991; 10(6):314-20. PubMed ID: 1935527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]